MoonLake ImmunotherapeuticsMLTXNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank80
3Y CAGR+194.6%
5Y CAGR+299.2%
Studio
Year-over-Year Change

Net other income and expenses outside core operations

3Y CAGR
+194.6%/yr
Annual compound
5Y CAGR
+299.2%/yr
Recent deceleration
Percentile
P80
Within normal range
vs 5Y Ago
1013.9x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$15.12M-31.7%
2024$22.13M+118.3%
2023$10.14M+1613.3%
2022$591732.00+1056.8%
2021$-61848.00-514.6%
2020$14917.00-